Project Abraham Inbox

July 8, Suspension of Clinical Trials
From: Colonel Grant Thompson To: Dr. Cassie Aklin, PhD Re: Suspension of Clinical Trials Date: November 3, 1950

Dr. Aklin,

Due to the violently unpredictable nature of our experiments thus far, we have suspended all injections until further notice. As the new psychiatric consult here at Project Abraham your professional assessments will be invaluable as we go forward with the project, but as for now, we are in a holding pattern. The bio-chem team is currently analyzing the data from our past attempts. We should have a better direction in the next few days and will be able to resume the testing protocol within the next two weeks.

Make use of this time to assess the remaining six candidates. As a result of the unexpected results to the first injection of serum, all personnel will be restricted to the Project Abraham compound. It is an inconvenience, but given the severity of the Alaskan winter, and this year's unexpectedly colder than normal temperatures, it is unlikely that many people would be venturing off base.

Remember, our work here is highly classified, so be sure to familiarize yourself with base procedures.

Sincerely, Col. Grant Thompson, U.S. Army

July 8, Clarification of Duties
To: Cassandra Aklin, PhD From: Colonel Thompson Re: Clarification of Duties Date: November 6, 1950

Per our conversation this memo will serve to clarify your duties.

You will monitor the psychological states of the subject of the trials both before the trials, and in the event that the serum proves less debilitating, after them. In particular, you are to watch for psychological changes that might be associated with exposure to the virus. These include but are not limited to, extreme rage, auditory and/or visual hallucinations, nightmares and any evidence of severe psychological disruptions.

Most importantly, each week the science staff will recommend three men they believe are biologically best suited to that week's trial. Based on your evaluations of the men themselves, and the group as a whole, you will forward to me a recommendation as to which man will be the subject of that week's trial.

Understand that though this is an immense burden, your service is essential to this project.

Sincerely, Col. Grant Thompson, U.S. Army

July 8, Lab Results for Joseph Capelli (Nov 7, 1950)
P.A. SUBJECT #492234RE NAME: Pvt. Joseph Capelli PEL# nc28439a

Dosage, 10% (microdose) engineered virus

Summary: At 09:22 hours, Private Capelli received an injection from the orderly on duty. This was a microdose test to determine how the serum acts in human body at subclinical dosages. The serum proved to be unexpectedly potent. The subject became withdrawn within a few hours and hysterical soon thereafter. Capelli was then restrained, at which point the serum rendered him delirious and eventually comatose.

Vital signs have since stabilized but patient shows no signs of returning to consciousness.

Recommendation: Reevaluate neural activator levels. Proceed with experiment after solving issue of synaptic disruption.

July 25
From: Thad Mornton, Security Officer To: All Project Abraham staffers

It has come to my attention that certain individuals on this base have been abusing their privileges on terminal-SRPA.net. We monitor all interfaces going into and out of our facilities, so be warned that your correspondence must be in accordance with all military rules and regulations.

Specifically, no member of this project should have any contact with the Alliance for American Autonomy. They say their motto is "America First, America Only," but in truth, they are a dangerous group that spreads lies and propaganda. Even if your intentions are altruistic, the Alliance must not be accessed from any government terminal.

Failure to follow regulations in this matter will result in serious disciplinary action.

Thank you and please consult me with any questions you may have.

Sincerely,

Thad Mornton

July 29, Lab Results for Channing Brown (Nov 14, 1950)
P.A. SUBJECT #764122AX NAME: Sgt Channing Brown PEL# dk62462a

Summary: Channing Brown received an experimental viral load intravenously at Alaska Daylight Time 14:56. Serum destroyed body's ability to clean up waste at the cellular level. This led to subsequent cellular breakdown particularly in fast growing cells lining digestive tract. The subject developed nausea that did not subside until the contents of his upper digestive system had been expelled from his body in their entirety. After the vomiting reached critical proportions, it became apparent that the sergeant's internal organs had liquefied and deposited their contents onto the hospital floor, alongside said vomit.

Recommendations: Cellular level metabolic function may be responding to dampening effects of enzyme production. Reconfigure accordingly before administering any further human testing.

July 29, Freiberghen Open-Association Test
To: Dr. Cassie Aklin From: U.S. War Department, Office of Psychological Protocol

Attached is a copy of the Freiberghen Open-Association Test, which we use to evaluate our soldiers' mental wellbeing and cognitive delineations. It has proven successful in categorizing levels of trauma both on the battlefield and during the difficult process of re-acclimating to normal society.

The Freiberghen Test is to be administered via a one-on-one session between a trained professional and the subject. His/her reactions must be monitored closely and recorded accurately.

We hope that this procedure is beneficial to your research as you move forward with Project Abraham.

August 5, Inkblot (Rorschach) Test
SPECIAL RESEARCH PROJECT ADMINISTRATION PSYCH EVALUATION

Dr. Aklin, Last week's psych evaluations were received. Results were...unexpected. Please follow-up with this test?

August 5 Lab Results, Post-Oster selection (Nov. 21, 1950)
P.A. SUBJECT #492132FB NAME: Sgt. Keith Oster PEL# bu75207b

Summary: The results of Sgt. Oster's injection were inconclusive due to a tragic chain of events. The subject's respiration was accelerated, his pulse elevated to dangerous levels and his pupil dilation irregular. Before the serum could be administered, however, the sergeant assaulted an orderly and was subdued by an attending soldier's firearm.

Keith Oster did not survive.

August 12, Lab Results for Glenn Khaner (Nov 28, 1950)
P.A. SUBJECT #47524UD NAME: Lt. Glenn Khaner PEL#nv92374a

Summary: Glenn Khaner received his injection at 15:43 hours in good spirits. He never attempted to struggle, even as the serum mutated his cell structure and triggered an unprecedented formation of new tissue in his brain cavity, neck and lungs.

Official cause of death: suffocation.

As horrific as the results may seem, this procedure brought us much longer to understanding how the vital strain works as it ravages a healthy human body. Lt. Khaner's autopsy will guide our biochemists in formulating the serum for next week's test case.

August 15, MEMO, Grant Thompson to Dr. Cassie Aklin, PhD (Dec 1, 1950)
MEMO From: Colonel Grant Thompson To: Dr. Cassie Aklin, PhD Re: Injection protocol change

Dr. Aklin, As you may or may not know, we have been in constant commu- nication with our team at Base Station Genesis, sharing vital information as we discover it. Project Abraham in- volves the work of many people at several installations. combining our efforts is essential. The scientific direc- tor over there, Dr. Fyodor Malikov, has made a potential breakthrough in his research, so he mailed us a sample of the latest serum that he has formulated. According to the medical data, it has had remarkable traction on subject Jordan Adam Shepherd.

In light of this development, we will be substituting the serum developed at this facility in favor of Malikov's new compound. Expectations are high that this week's experi- ment could be the answer we've been looking for as we forge ahead with Project Abraham.

Sincerely,

Col. Grant Thompson

August 15, MEMO, Grant Thompson to All Base Personnel (Dec 1, 1950)
MEMO From: Colonel Grant Thompson Date: December 1, 1950

It has recently come to my attention that one of our secu- rity officers was conducting improper surveillance on fellow Project Abraham staffers. He has since been placed on unpaid leave indefinitely. Matters of security are not to be used to justify such behavior; the U.S. military will not tolerate it in any form.

We can never underestimate the cunning of our foe. As a great man once said, "In case of defense, it's best to weigh the enemy mightier than he seems."

Sincerely, Col. Grant Thompson

SC48772132/GT/SP

August 19, Lab Results, Post-Hale selection (Dec 5, 1950)
P.A. Medical Facility

December 5th, 1950

Attention: Dr. Cassie Aklin

This week's experiment will be crucial in pinpointing the missing variable in our serum composition. We have altered the serum in an effort to compensate for the metabolic side effects seen in the last injection. Please do not tarry in your selection process, as we are gearing up to make our final breakthrough with this next injection.

Should be this week's soldier? Or is Danby more prepared, in your professional estimation?

Authorized Signature,

August 26, Lab Results, Post-Gennaro selection (Dec 12, 1950)
P.A. Medical Facility

December 12th, 1950

Attention: Dr. Cassie Aklin

Although our research has not yielded a cure to the deadly virus that we have been striving to combat, we have achieved some considerable successes along the way. Sgt. Hale has recuperated nicely and his natural antibody production will be essential in future studies. That is why we are forwarding his lab results on to Bryce Canyon, where Dr. Fyodor Malikov will take the proverbial baton and run with it. He has been formulating an "inhibitor serum" for the past several months; perhaps his findings will coalesce with ours and bring all of our hard work to fruition.

On a personal note, we all wish you the best of luck in your future endeavors. Wherever your next post will be, they are fortunate to have a thoughtful, precise mind like yours at their disposal.

Farewell, Cassie

Authorized Signature

August 29
MEMO From: Colonel Grant Thompson To: Dr. Cassie Aklin, PhD December 15th, 1950

Effective immediately, the viral experimentation we have been conducting over these past six weeks will halt and all future initiatives will be performed at Base Station Genesis. Although Lt. Danby has been prepped for injection, his procedure will not be necessary, as conflicting data has arisen from Dr. Fyodor Malikov's latest research. Our serum configuration is not in accordance with the compound Malikov is now using and, therefore, it would do more harm than good.

Please notify the members of your respective staffs about our new procedure. We still have a lot of work to do before this operation can transition, in its entirety, to the Bryce Canyon facility.

Thank you for your hard work; we have all made sacrifices along the way to aid in the steady progress of Project Abraham. The military appreciates your efforts, mourns our immense losses, and recognizes what we may have gained, in turn.

Sincerely, Col. Grant Thompson